SCHEMBL6984731

SCHEMBL6984731

CCCC(=O)CNc1ccc2c(c1)CCCN2C(=O)CCc1ccc(C#N)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.45
NR3C1 P04150 2/20 0.41
FPR1 P21462 4/20 0.40
FPR2 P25090 4/20 0.40
AVPR2 P30518 1/20 0.39
BRD4 O60885 1/20 0.39
CREBBP Q92793 1/20 0.39
HDAC1 Q13547 2/20 0.39
HDAC8 Q9BY41 2/20 0.39
HDAC6 Q9UBN7 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
ALDH1A1 P00352 2/20 0.39
USP2 O75604 1/20 0.39
HPGD P15428 1/20 0.39
TSHR P16473 1/20 0.39
HSD17B10 Q99714 1/20 0.39
PARP1 P09874 1/20 0.38
NPC1 O15118 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6976282 0.88 TP53 (0.44) TP53NR3C1FPR1FPR2AVPR2
SCHEMBL6986432 0.86 TP53 (0.48) TP53NR3C1FPR1FPR2AVPR2
Hydrochloric Acid SCHEMBL6985441 0.85 NR3C1 (0.41) NR3C1AVPR2BRD4CREBBPMEN1
SCHEMBL6981983 0.85 RAB9A (0.46) TP53NR3C1FPR1FPR2HDAC1
SCHEMBL6976631 0.83 HSD17B3 (0.46) TP53NR3C1FPR1FPR2MEN1
SCHEMBL6984804 0.83 KCNH2 (0.45) TP53FPR1FPR2AVPR2HDAC1
SCHEMBL6982938 0.83 NR3C1 (0.51) TP53NR3C1FPR1FPR2BRD4
SCHEMBL6977731 0.82 TP53 (0.45) TP53FPR1FPR2BRD4CREBBP
SCHEMBL6984139 0.81 NR3C1 (0.50) TP53NR3C1BRD4CREBBPMEN1
SCHEMBL6985994 0.81 POLB (0.43) TP53NR3C1FPR1FPR2BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed